Hony completely divested itself of CSPC Pharmaceutical equity .
Through firms it controls , Hony Capital sold off about US $1.26 billion in stock in CSPC Pharmaceutical in April 2015 to take advantage of rising share prices .
Hony Capital completely divested itself of CSPC Pharmaceutical equity .
Through firms it controls , Hony Capital sold off about US $1.26 billion in stock in CSPC Pharmaceutical in April 2015 to take advantage of rising share prices .